Donggou (David) He, MD, PhD
CMC Advisory Board Director
David is a highly experienced professional in Biologics and Cell Therapeutics development and manufacturing. With extensive leadership background, he excels in managing multinational teams and has a strong track record in CMC R&D. His expertise includes process development, technology transfer, clinical and commercial manufacturing, and regulatory filings. David holds an MD and Ph.D. in Immunology. Currently CTO of Iaso Biotechnology, he previously served as CTO of Legend Biotech, contributing significantly to the industry’s advancements.